This post is a tribute to the late Dr. Yoshiki Sasai (笹井芳樹). If you would like your name added to this tribute please let me know. You are also welcome to add your own tributes in the comments. In an era when the emerging field of regenerative medicine is just beginning to take wing, we […]
Stem Cell Community Tribute to Yoshiki Sasai (笹井芳樹) Read More »
Is there real promise of stem cells for autism? At this point the jury remains out on that question, but a growing number of kids are nonetheless getting such “treatments” at for-profit dubious clinics. Academic clinical researchers are interested in this area as well. Still, the potential use of stem cells to treat autism is
Duke Launches Large, Debated Stem Cells for Autism Trial Read More »
By Jeanne Loring Last week I visited NIST, the National Institute for Standards and Technologies in Gaithersburg, Maryland as a member of a review panel. NIST is the science branch of the US Department of Commerce, which is the business part of the government, and is not officially associated with other acronyms, the NIH, NSF,
The Measurers Size Up Stem Cells Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »
Sometimes there is so much craziness and outright bad stuff going on out there around the world related to stem cells that we can lose sight of all the good news and encouraging developments as well. I think the new paper (Chen, et al.) from a team led by Drs. Lane and Loring is good news.
What are important, recent stem cell good news stories? Read More »
A small group of the STAP authors via RIKEN have now released a detailed protocol also available at Nature Protocol Exchange for making STAP stem cells entitled “Essential technical tips for STAP cell conversion culture from somatic cells”. This comes about 5 weeks after publication of their Nature STAP stem cell papers. 2020 update: With the 4th and
Reactions to RIKEN’s STAP cell protocol Read More »
What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time
Interview with Robert Klein on CIRM’s Future Read More »
Update: I’ve set up a STAP new data page where people can share their results, thoughts, etc. The report of STAP stem cells has shaken things up. The idea that you can easily make powerful stem cells with a simple acid treatment or other sources of cellular stress has definitely caught the attention of the world of
Invitation to crowdsource STAP stem cell follow up data here Read More »
Who might make a fantastic new CIRM President? The California stem cell community is abuzz with this question. This new President will not only lead CIRM today, but also in all likelihood will steer CIRM in its new incarnation after 2017, what I’ve called CIRM 2.0. At least that would be ideal. CIRM has posted a
Dozen Candidates To Be New CIRM President Read More »
ABC News just reported that the FDA is allgedly “cracking down” on the publicly traded company, MiMedx (MDXG), which sells a placental derivative touted for healing powers. The Wall Street Journal is also following the story. According to ABC News: MiMedx is a publically traded, for-profit company that takes donated human placentas — solicited via a website featuring
MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit Read More »